India to Botswana: Dolutegravir Export Trade Route

The India to Botswana Dolutegravir corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $3.2B USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's dolutegravir manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $53.7M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 32.2%, placing it at rank #13 among India's top dolutegravir export destinations globally.

On the import side, key buyers of Indian dolutegravir in Botswana include AFRICURE PHARMACEUTICALS BOTSWANA(P, AFRICURE PHARMACEUTICALS BOTSWANA, PREMIER PHARMA TRADE (PTY.) LTD. and 16 others. AFRICURE PHARMACEUTICALS BOTSWANA(P is the single largest importer with 2 shipments valued at $3.1B USD.

India's dolutegravir exports to Botswana are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 35 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Botswana benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $53.7M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lamivudine 300mg + tenofovir disoproxilfumarate 300mg + dolutegravir sodium 50mg tablets ps: 1x30s and lamivudine 300mg + tenofovir disoproxilfumarate 300mg + dolutegravir sodium 50mg tablets ps: 1x30s **nos, suggesting that buyers in Botswana tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AFRICURE PHARMACEUTICALS BOTSWANA(P is the largest importer with 2 shipments worth $3.1B USD — representing 99% of all dolutegravir imports from India on this route. A total of 19 buyers are active on this corridor.